QuickView for negative regulation of receptor biosynthetic process (biogroup)

1. L1000 CMAP - Breast cancer MCF7.101 cells with CRISPR targeted gene knockouts
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

There were no matches for negative regulation of receptor biosynthetic process

1. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
2. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …